Search Results - "Drug design

QSAR and strategies in the design of bioactive compounds proceedings of the Fifth European Symposium on Quantitative Structure-Activity Relationships, Bad Segeberg, 1984

Subjects: “…Drugs congresses design…”
Click Here to View Status and Holdings.

Immunotoxicology strategies for pharmaceutical safety assessment

Subjects: Click Here to View Status and Holdings.

Portfolio, program, and project management in the pharmaceutical and biotechnology industries

Subjects: Click Here to View Status and Holdings.

Pharmaceutical product development insights into pharmaceutical processes, management and regulatory affairs

Subjects: Click Here to View Status and Holdings.

Applying genomic and proteomic microarray technology in drug discovery by Matson, Robert S.

Subjects: “…Drug Design…”
Click Here to View Status and Holdings.

Mass spectrometry in drug metabolism and disposition basic principles and applications

Subjects: “…Drug Design…”
Click Here to View Status and Holdings.

PAT applied in biopharmaceutical process development and manufacturing an enabling tool for quality-by-design

Click Here to View Status and Holdings.

Handbook of drug screening

Table of Contents: “…Moving into the third millennium after a century of screening -- Basic considerations in designing high-throughput screening assays -- Screening platforms -- Homogeneous assays for high-throughput and ultrahigh-throughput screening -- Microbe-based screening systems -- Molecular genetic screen design for agricultural and pharmaceutical product discovery -- Receptor screens for small molecule agonist and antagonist discovery -- Functional assay screens -- Enzyme screens -- Screening strategies for ion channel targets -- High-throughput screening assays for detection of transcription -- Screening of combinatorial biology libraries for natural products discovery -- Higher-throughput screening assays with human hepatocytes for hepatotoxicity, metabolic stability, and drug-drug interaction potential -- High-throughput screening for metabolism-based drug-drug interactions -- The ATCG of drug discovery -- Genomics/functional proteomics for identification of new targets -- Bioinformatics: identification of novel targets and their characterization -- The evolution of laboratory automation -- Robotics and automation -- Assay miniaturization: developing technologies and assay formats -- Screening in the NanoWorld: single-molecule spectroscopy and miniaturized high-throughput screening.…”
Click Here to View Status and Holdings.

Drug Safety Evaluation Methods and Protocols

Click Here to View Status and Holdings.

Poorly Soluble Drugs

Click Here to View Status and Holdings.

Handbook on injectable drugs by Trissel, Lawrence A.

Click Here to View Status and Holdings.

Therapeutic drug monitoring

Click Here to View Status and Holdings.

Stockleys drug interactions a source book of interactions, their mechanisms, clinical importance, and management

Click Here to View Status and Holdings.

QSAR Hansch analysis and related approaches by Kubinyi, Hugo

Subjects: Click Here to View Status and Holdings.

Chemical biology from small molecules to systems biology and drug design

Subjects: Click Here to View Status and Holdings.

Solid state characterization of pharmaceuticals

Subjects: Click Here to View Status and Holdings.

Peptidomimetics in organic and medicinal chemistry by Trabocchi, Andrea

Subjects: “…Drug Design…”
Click Here to View Status and Holdings.

The management of clinical trials

Subjects: Click Here to View Status and Holdings.

Handbook of assay development in drug discovery

Subjects: Click Here to View Status and Holdings.

Trends in medicinal chemistry '90 proceedings of the XIth international symposium on medicinal chemistry, held in Jerusalam, Israel, 2-7 September 1990

Subjects: “…Drugs Design…”
Click Here to View Status and Holdings.